Robert Forrester is an accomplished biotechnology executive with extensive experience in founding and directing multiple innovative companies. Currently serving as Executive Chairman at Anagenex and Co-Founder and Director at Sesame Therapeutics and IDRx, Robert focuses on advancing cancer therapies and drug discovery through cutting-edge technologies and AI. With a strong background in oncology, immunotherapy, and precision medicine, Robert has held key leadership roles at companies such as OnCusp Therapeutics, Deciduous Therapeutics, and Brixton Biosciences. Robert’s academic credentials include a Bachelor of Laws from the University of Bristol and further studies at the University of Law Guildford and London Business School.